JP Morgan Call 92 CF 17.05.2024/ DE000JK2QXV6 /
15.05.2024 9:17:22 | Изменение-0.002 | Бид12:41:22 | Предложение12:41:22 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.004EUR | -33.33% | 0.004 Величина цены спроса: 1,000 |
0.094 Величина цены предложения: 1,000 |
CF Industries Holdin... | 92.00 USD | 17.05.2024 | Call |
GlobeNewswire
13:15
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at ...
GlobeNewswire
13:03
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire
13:01
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presente...
GlobeNewswire
13:00
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GlobeNewswire
13:00
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
GlobeNewswire
13:00
Dorman Products expands its catalog of cost-saving and aftermarket-exclusive repair solutions
GlobeNewswire
13:00
Plug to Revolutionize Middle-Mile Delivery with Class 6 Fuel Cell Electric Truck Integration
GlobeNewswire
13:00
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:00
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
13:00
Boralex announces a substantial 62% increase in net earnings and continued disciplined development o...
GlobeNewswire
13:00
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
13:00
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the ...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница